This inventor holds 4 USPTO granted patents and 20 published patent applications and 2 EPO patents. Top assignees: The University of Texas System, Johns Hopkins University, The State University of New York. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2025-2026
Title: The Innovative Contributions of Samir Hanash
Introduction
Samir Hanash is a notable inventor based in Houston, Texas, recognized for his significant contributions to cancer detection and treatment. With two patents to his name, Hanash has made strides in the medical field, particularly in the early detection of lung cancer and the assessment of various cancer types.
Latest Patents
Hanash's latest patents include "Methods for the detection and treatment of lung cancer," which provides methods and related kits for the early detection of lung cancer and assessing the risk of harboring the disease. Another patent, "Methods and materials for assessing and treating cancer," outlines innovative methods and materials for detecting and treating cancer in subjects, including humans. This patent emphasizes the detection of multiple classes of biomarkers and the presence of aneuploidy, enhancing the sensitivity and specificity of cancer detection.
Career Highlights
Throughout his career, Hanash has worked with prestigious institutions, including the University of Texas System and The Johns Hopkins University. His work has focused on developing advanced methodologies for cancer diagnosis and treatment, contributing to the broader understanding of cancer biology.
Collaborations
Hanash has collaborated with esteemed colleagues in the field, including Bert Vogelstein and Kenneth W. Kinzler. These collaborations have furthered research efforts and innovations in cancer detection and treatment.
Conclusion
Samir Hanash's contributions to cancer research and his innovative patents highlight his commitment to improving medical diagnostics and treatment options. His work continues to impact the field of oncology significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile